Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Andreeff

Showing results (31-40 of 503) with videos related to

Pageof 51
Sort By:
Blood|July 18, 2008
Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemiaKensuke Kojima, Marina Konopleva, Twee Tsao, et al.
Expert Opinion on Investigational Drugs|April 23, 2014
Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemiaNaveen Pemmaraju, Hagop Kantarjian, Michael Andreeff, et al.
Seminars in Hematology|September 30, 2010
The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?Bing Z Carter, Duncan H Mak, Jorge Cortes, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 9, 2023
Determination of Radiation Exposure of Individuals in the Population by Patients after Radioiodine Therapy - Comparison of two Measurement SystemsHolger Hartmann, Michael Andreeff, Jörg Claußnitzer, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2022
Beyond BCL-2 Inhibition in Acute Myloid Leukemia: Other Approaches to Leverage the Apoptotic PathwayAbhishek Maiti, Bing Z Carter, Michael Andreeff, et al.
Pharmacology & Therapeutics|June 7, 2015
Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) proteinJo Ishizawa, Kensuke Kojima, Numsen Hail, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2014
Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102John M Fidler, Jinhua An, Bing Z Carter, et al.
The Journal of Investigative Dermatology|July 13, 2004
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cellsChunlei Zhang, Xiao Ni, Marina Konopleva, et al.
Oncoscience|January 17, 2015
The combinatorial complexity of cancer precision medicineFrederick Klauschen, Michael Andreeff, Ulrich Keilholz, et al.
The Journal of Biological Chemistry|January 9, 2004
Evidence supporting a role for calcium in apoptosis induction by the synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO)Numsen Hail, Marina Konopleva, Michael Sporn, et al.
Pageof 51

Showing results (31-40 of 503) with videos related to

Sort By:
Pageof 51
Blood|July 18, 2008
Concomitant inhibition of Mdm2-p53 interaction and Aurora kinases activates the p53-dependent postmitotic checkpoints and synergistically induces p53-mediated mitochondrial apoptosis along with reduced endoreduplication in acute myelogenous leukemiaKensuke Kojima, Marina Konopleva, Twee Tsao, et al.
Expert Opinion on Investigational Drugs|April 23, 2014
Investigational FMS-like tyrosine kinase 3 inhibitors in treatment of acute myeloid leukemiaNaveen Pemmaraju, Hagop Kantarjian, Michael Andreeff, et al.
Seminars in Hematology|September 30, 2010
The elusive chronic myeloid leukemia stem cell: does it matter and how do we eliminate it?Bing Z Carter, Duncan H Mak, Jorge Cortes, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|May 9, 2023
Determination of Radiation Exposure of Individuals in the Population by Patients after Radioiodine Therapy - Comparison of two Measurement SystemsHolger Hartmann, Michael Andreeff, Jörg Claußnitzer, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 30, 2022
Beyond BCL-2 Inhibition in Acute Myloid Leukemia: Other Approaches to Leverage the Apoptotic PathwayAbhishek Maiti, Bing Z Carter, Michael Andreeff, et al.
Pharmacology & Therapeutics|June 7, 2015
Expression, function, and targeting of the nuclear exporter chromosome region maintenance 1 (CRM1) proteinJo Ishizawa, Kensuke Kojima, Numsen Hail, et al.
Cancer Chemotherapy and Pharmacology|March 13, 2014
Preclinical antileukemic activity, toxicology, toxicokinetics and formulation development of triptolide derivative MRx102John M Fidler, Jinhua An, Bing Z Carter, et al.
The Journal of Investigative Dermatology|July 13, 2004
The novel synthetic oleanane triterpenoid CDDO (2-cyano-3, 12-dioxoolean-1, 9-dien-28-oic acid) induces apoptosis in Mycosis fungoides/Sézary syndrome cellsChunlei Zhang, Xiao Ni, Marina Konopleva, et al.
Oncoscience|January 17, 2015
The combinatorial complexity of cancer precision medicineFrederick Klauschen, Michael Andreeff, Ulrich Keilholz, et al.
The Journal of Biological Chemistry|January 9, 2004
Evidence supporting a role for calcium in apoptosis induction by the synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO)Numsen Hail, Marina Konopleva, Michael Sporn, et al.
Pageof 51